-
-
-
Refugees resettling to the United States and other developed countries frequently suffer from infectious diseases, and can pose diagnostic or therapeutic dilemmas for health care providers in their new homes.
-
This multicenter, randomized, placebo-controlled trial of a synthetic GHRH analogue, tesamorelin (1-44 amino acids from the amino terminal of GHRH with a trans-3-hexenoyl group added to the amino terminal to increase the half-life over native GHRH), randomized 412 patients (86% male) to daily subcutaneous tesamorelin vs placebo for 26 weeks.
-
Sixty-one hospitals in 28 countries participated in a prospective cohort study of hospitalized patients with definite endocarditis.
-
The diagnosis of malaria has traditionally relied upon microscopy. However, microscopic diagnosis is labor intensive and somewhat subjective, and assurance of quality standards can be difficult at best.
-
In this issue: Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
-
This single-center, retrospective study examined ICU mortality and various risk factors among critically ill patients who developed bacteremia during their VAP episode.
-
Use of specially trained palliative care teams in the ICU has increased in frequency in recent years. Consultation by these teams tends to occur very late in patients' length of stay. Few studies have been performed evaluating outcomes, such as length of stay.
-
Invasive aspergillosis (IA) is increasingly recognized as a source of infection in immunocompromised ICU patients, but accurate diagnosis remains challenging.
